Final Programme

Postgraduate Educational Programme
A-085 16:30
High resolution MDCT enterography
J. Fletcher; Rochester, MN/US
Learning Objectives:
1. To understand normal and abnormal contrast enhancement patterns of the small bowel wall on CT.
2. To understand common and uncommon MDCT enterography fi ndings and their diagnostic value, with
special attention to different subtypes of Crohn’s disease infl ammation.
3. To understand the relative strengths and weaknesses of CT enterography compared with MR
enterography and cross-sectional enteroclysis.
A-086 16:55
Basic and advance MR contrast mechanisms
N. Papanikolaou; Iraklion/GR
Learning Objectives:
1. To review basic contrast mechanisms (T1, T2) in characterising small bowel wall pathology.
2. To present novel contrast mechanisms (diffusion, perfusion magnetisation transfer) in characterising small
bowel wall pathology.
3. To discuss enhancement patterns of the bowel wall in differentiating infl ammation and fi brosis.
Panel discussion 17:20
16:00 - 17:30 Room N/O
Molecular Imaging
RC 406
MR contrast agents in clinical and experimental use
Moderator: A. Filippone; Chieti/IT
A-087 16:00
A. Blood pool agents
E. Canet Soulas; Bron/FR
Learning Objectives:
1. To understand mechanisms of action of MR contrast agents for MRA and what is the r1 relaxivity of a
contrast agent.
2. To learn about new developments of blood pool MR contrast agents.
3. To discuss contrast agents and vessel wall imaging.
A-088 16:30
B. Cell specifi c agents
G. Morana; Treviso/IT
Learning Objectives:
1. To understand the mechanism of uptake of cell specifi c agents.
2. To learn about the advantages of clinical use of cell specifi c agents.
3. To understand the possibilities of differential diagnosis using cell specifi c agents.
A-089 17:00
C. New applications of MR contrast agents
H.E. Daldrup-Link; San Francisco, CA/US
Learning Objectives:
1. To get an overview on new applications of established MR contrast agents.
2. To learn about various new MR contrast agents for clinical and experimental use.
3. To gain knowledge about up to date in vivo cell tracking techniques with MR imaging.
158 A B C D European Society of Radiology